Significant pain reduction with oral methotrexate in knee osteoarthritis; results from the promote randomised controlled phase iii trial of treatment effectiveness

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2019.02.120 ◽

2019 ◽

Vol 27 ◽

pp. S84-S85

Author(s):

S.R. Kingsbury ◽

P. Tharmanathan ◽

A. Keding ◽

B. Corbacho ◽

F.E. Watt ◽

...

Keyword(s):

Knee Osteoarthritis ◽

Treatment Effectiveness ◽

Pain Reduction ◽

Phase Iii ◽

Phase Iii Trial ◽

Oral Methotrexate ◽

Significant Pain ◽

Randomised Controlled

Pain Reduction with Oral Methotrexate in knee Osteoarthritis: a pragmatic phase III trial of Treatment Effectiveness

http://isrctn.org/> ◽

10.1186/isrctn77854383 ◽

2013 ◽

Author(s):

Sarah Hogg

Keyword(s):

Knee Osteoarthritis ◽

Treatment Effectiveness ◽

Pain Reduction ◽

Phase Iii ◽

Phase Iii Trial ◽

Oral Methotrexate

Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-015-0602-8 ◽

2015 ◽

Vol 16 (1) ◽

Cited By ~ 14

Author(s):

Sarah R Kingsbury ◽

Puvan Tharmanathan ◽

Nigel K Arden ◽

Michael Batley ◽

Fraser Birrell ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Knee Osteoarthritis ◽

Study Protocol ◽

Treatment Effectiveness ◽

Controlled Trial ◽

Pain Reduction ◽

Phase Iii ◽

Phase Iii Trial ◽

Oral Methotrexate ◽

Randomized Controlled

Faculty Opinions recommendation of Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1088946.542079 ◽

2007 ◽

Author(s):

Jonathan Schapiro

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Trial ◽

Randomised Controlled

OC-086 Surgery alone vs chemoradiotherapy followed by surgery for stage I and II oesophageal cancer: final analysis of a randomised controlled phase III trial—FFCD 9901

Gut ◽

10.1136/gutjnl-2012-302514a.86 ◽

2012 ◽

Vol 61 (Suppl 2) ◽

pp. A37.2-A38

Author(s):

W B Robb ◽

C Mariette ◽

L Dahan ◽

E Maillard ◽

F Mornex ◽

...

Keyword(s):

Oesophageal Cancer ◽

Final Analysis ◽

Stage I ◽

Phase Iii ◽

Phase Iii Trial ◽

Randomised Controlled

Correction:Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer

BMJ Open ◽

10.1136/bmjopen-2017-020690corr1 ◽

2019 ◽

Vol 9 (5) ◽

pp. e020690corr1 ◽

Cited By ~ 1

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Stereotactic Ablative Radiotherapy ◽

Radical Radiotherapy ◽

Small Cell Lung ◽

Standard Chemotherapy ◽

Phase Iii Trial ◽

Randomised Controlled

Faculty Opinions recommendation of A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.730373333.793553318 ◽

2018 ◽

Author(s):

Kellie Mathis

Keyword(s):

Rectal Cancer ◽

Trial Design ◽

Controlled Trial ◽

Poor Response ◽

Phase Iii ◽

Tumour Regression ◽

Tumour Regression Grade ◽

Phase Iii Trial ◽

Randomised Controlled ◽

Regression Grade

Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial

The Lancet Oncology ◽

10.1016/s1470-2045(05)70100-5 ◽

2005 ◽

Vol 6 (5) ◽

pp. 287-294 ◽

Cited By ~ 34

Author(s):

Andrew Bottomley ◽

Patrick Therasse ◽

Martine Piccart ◽

Fabio Efficace ◽

Corneel Coens ◽

...

Keyword(s):

Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related ◽

Randomised Controlled

Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial

BMC Cancer ◽

10.1186/1471-2407-11-310 ◽

2011 ◽

Vol 11 (1) ◽

Cited By ~ 93

Author(s):

Nicolas Briez ◽

Guillaume Piessen ◽

Franck Bonnetain ◽

Cécile Brigand ◽

Nicolas Carrere ◽

...

Keyword(s):

Phase Iii ◽

Phase Iii Trial ◽

Open Versus ◽

Randomised Controlled

Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II–III colorectal cancer: a multicentre randomised controlled phase III trial

The Lancet Oncology ◽

10.1016/s1470-2045(05)70222-9 ◽

2005 ◽

Vol 6 (7) ◽

pp. 459-468 ◽

Cited By ~ 34

Author(s):

Bernard Nordlinger ◽

Philippe Rougier ◽

Jean-Pierre Arnaud ◽

Muriel Debois ◽

Jaques Wils ◽

...

Keyword(s):

Colorectal Cancer ◽

Systemic Chemotherapy ◽

Regional Chemotherapy ◽

Stage Ii ◽

Phase Iii ◽

Phase Iii Trial ◽

Randomised Controlled

HYPOfractionated Radiation Therapy comparing a standard radiotherapy schedule (over three weeks) with a novel one week schedule in Adjuvant breast cancer: An open-label randomised controlled study (HYPORT- Adjuvant): study protocol for a multicenter, randomized phase III trial.

Authorea ◽

10.22541/au.158706172.25469148 ◽

2020 ◽

Author(s):

Sanjoy Chatterjee ◽

santam chakraborty ◽

HYPORT Adjuvant Author Group

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Phase Iii ◽

Controlled Study ◽

Open Label ◽

Phase Iii Trial ◽

Randomised Controlled Study ◽

Adjuvant Breast Cancer ◽

Randomised Controlled ◽

Hypofractionated Radiation